FDA announces recall of certain Dexcom glucose monitoring devices

3 hours ago 1

Comments

Girl with diabetes is reading the glucose levels using device for continuous glucose monitoring in blood – CGM. She shows daily graph on screen. Diabetes type 1. Insulin depend

The U.S. Food and Drug Administration has announced a recall of specific Dexcom (NASDAQ:DXCM) glucose monitoring devices, including the G6, G7, ONE, and ONE+ models.

The recall is due to a potential issue with the speaker that may prevent the

Recommended For You

More Trending News

Read Entire Article

FDA announces recall of certain Dexcom glucose monitoring devices

Recommended For You

More Trending News

Related

Amazon’s AWS has joined the AI agent craze. Now the real wor...

Nouveau Monde Graphite, Northern Graphite surge as U.S. set ...

Great Southern Bancorp signals margin stability and capital ...

Snap-on sees improving Tools Group momentum and resilient ma...

FTC reverses orders barring John Hess from Chevron board, Sh...

Google digital advertising trial delayed in Texas

A CEO was caught hugging his chief product officer during a ...

Here are the major earnings before the open tomorrow

Gold edges lower on stronger dollar, easing fears of Powell ...

The first skydiver to break the speed of sound has died in a...

‘He really turned the tide’: Oyster people cheer La. Gov. ca...

Trump said to broaden 401(k) access to crypto investments

ClearSign files $50M mixed securities shelf

Where’s the beef? Hamburger inflation is running at 12% as A...

GE Aerospace snaps six straight sessions of gains

FOXO Technologies announces reverse stock split

Hyliion secures $1.5M contract from U.S. Navy

RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. 4.375...

Nike files automatic mixed securities shelf

Rezolute files to sell 1.3M shares of common stock for holde...

Trending

Popular

بانک مرکزی: بابک زنجانی مجوز فعالیت اقتصادی ندارد

پنج مصدوم براثر تصادف پراید با دیوار در گنبدکاووس